1st Circ. Revives Part Of Securities Suit Against Ariad
The First Circuit will let a small part of a securities fraud class action against Ariad Pharmaceuticals Inc. continue, but upheld a district court judge's dismissal of the rest of the...To view the full article, register now.
Already a subscriber? Click here to view full article